Recent procurements of medicinal products for the blood, blood-forming organs and the cardiovascular system in Ireland
2023-06-13Fibrinogen concentrate used for congenital afibrinogenaemia and dysfibrinogenaemia (Irish Blood Transfusion Service)
Human fibrinogen concentrate is used for congenital afibrinogenaemia and dysfibrinogenaemia states for treatment of bleeding complications. It is also used in acquired hypofibrinogenemia conditions such as massive haemorrhage, acquired coagulopathy, liver disease with bleeding and in obstetric haemorrhage. The product should be licensed for these clinical indications and approved by the HPRA. Fibrinogen, in presence of thrombin, activates FVIII and calcium, which is necessary to convert fibrinogen into …
View the procurement »
2019-02-26The Supply and Commissioning of Extracorporeal Membrane Oxygenation Equipment for Use in Donation after Circulatory Death (Beaumont Hospital)
The Contracting Authority, in the first instance, intends to establish a contract for the supply and commissioning of Extracorporeal Membrane Oxygenation equipment for use in donation after circulatory death. Initially, the successful tenderer will be required to supply and commission the required equipment. Following the expiry of a warranty period of 12 months’ duration, a support and maintenance contract of 4 years’ duration will be awarded. The Contracting Authority reserves the right, upon the …
View the procurement » Mentioned suppliers:Maquet Ltd
2015-09-09The Provision of Recombinant Factor VIII (St James's Hospital)
Invitation to tender for the Provision of Recombinant Factor VIII to St James's Hospital (SJH), the Irish Blood Transfusion Board (IBTS), the Health Service Executive (HSE) and the Health Care Executive funded agencies collectively known as the Contracting Agency (CA).
View the procurement »